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Abstract: Cnr2 is one of two cannabinoid receptors known to regulate bone 
 metabolism. Here, we compared the whole bone properties of femora and tibiae from 
three-month-old Cnr2−/− mice with wild-type controls using a C57BL/6 background. 
Bending stiffness was measured by three-point bending. The elastic  modulus, density 
and mineral content were measured using ultrasound, Archimedes’ principle and 
ashing. Micro-CT was used to measure the second moment of area, inner and outer 
perimeters of the cortical shaft and trabecular parameters. Deleting Cnr2 increased 
the bending stiffness by increasing the second moment of area. Bone from affected 
male mice had a greater modulus than controls, although no  difference was  
observed in females. The fractional volume of trabecular bone was greater in Cnr2−/− 
 females than controls, while no difference was seen in males. These data indicate 
that inactivating Cnr2 increases the amount of cortical bone in both males and 
females at 3 months of age, but the effect on trabecular bone is different in the two 
sexes. These findings extend previous studies looking only at trabecular bone and 
provide further support for the possible use of Cnr2 antagonists for improving bone 
properties that may be of value in the treatment of bone disorders.
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1. Introduction
Recent studies have indicated a role for the cannabinoid receptors, Cnr1 and Cnr2, in bone metabo-
lism (Bab, 2007; Idris & Ralston, 2010; Idris et al., 2009; Ofek et al., 2006) and shown that they play 
distinct roles in regulating bone mass and bone turnover. The cells that produce and maintain bone, 
osteoblasts, osteoclasts and osteocytes all express the Cnr2 receptor (Ofek et al., 2006), yet meas-
urements of the bone phenotype are contradictory. Ofek et al. (2006) reported that targeted inacti-
vation of the Cnr2 receptor (Cnr2−/−) led to a reduction in the peak trabecular bone mass in both 
males and females, and resulted in trabecular osteoporosis and cortical expansion in 12 month-old 
mice. This, it was suggested, was due to an increase in osteoclast number and a high bone turnover. 
A study by Idris, Sophocleous, Landao-Bassonga, van’t Hof, and Ralston (2008), however, found no 
difference in peak bone mass between Cnr2−/− mice and wild-type (WT) controls but showed that 
bone loss following ovariectomy (OVX) was reduced in Cnr2−/− mice, suggesting that inactivating 
Cnr2 mitigates the severe osteoporosis induced by OVX. They agreed, though, that this seemed to be 
due to a modulation of osteoclastic activity. In a later study, they again reported that bone mass and 
bone turnover were unchanged by inactivating Cnr2 in young (three-month-old) mice although they 
found an increased activity of bone-forming osteoblasts, and an increase in osteoclast number 
(Sophocleous, Landao-Bassonga, van’t Hof, Idris, & Ralston, 2011). By 12 months of age, however, 
the mice had developed osteoporosis due to high bone turnover and uncoupling of bone formation 
from resorption (Sophocleous et al., 2011).
These studies have resulted in suggestions that Cnr2 agonists might have considerable value as 
anabolic agents for treating osteoporosis (Ofek et al., 2006; Sophocleous et al., 2011), while an 
inverse agonist might protect against bone loss (Sophocleous et al., 2011). In this context, as animal 
models are crucial to our understanding of the mechanisms of action, it is important that we 
understand fully the phenotype of both cortical and trabecular bone in Cnr2−/− mice and whether 
there are differences related to the sex of the animals. To explore this further, we obtained Cnr2−/− 
mice on a C57BL/6 background and measured the mechanical and material properties of both 
cortical and trabecular bone in both males and females.
2. Materials and methods
2.1. Animals
A colony of C57BL/6 Cnr2−/− mice (KO) was generated for an unrelated study by homologous recom-
bination, as described previously (Buckley et al., 2000) and kept under standard conditions in accord-
ance with UK Home Office regulations. Mice were euthanised at the age of 12 weeks and 10 KO mice 
(five male, five female) were made available for this study. Age-matched WTs of the same strain 
were used as controls (four male, five female). The hind limbs were removed, and the femur and tibia 
separated and cleaned. The bones were wrapped in gauze soaked in phosphate-buffered saline, 
sealed in bags and stored at −20°C until measurements were made.
2.2. Mechanical and material properties
The properties of long bones were measured as described previously (Goodyear & Aspden, 2012; 
Huesa et al., 2011). Briefly, the mechanical properties of cortical bone were measured by subjecting 
each tibia and femur to three-point bending using an Instron 5564 materials testing machine 
(Instron, High Wycombe). The cross-head speed was 1.0  mm  min−1 and the span was 9.93  mm. 
Bending stiffness, load to failure and strength were calculated from the resulting load-displacement 
graphs. The elastic modulus of the bone matrix was calculated from the product of the square of the 
speed of sound, measured ultrasonically, and the bone density, measured by Archimedes’ principle. 
The mineral content of the bone matrix was expressed as a fraction of the dry weight, and deter-
mined by ashing the dried bones at 600°C for 24 h (Mkukuma et al., 2003).
The proximal tibia and distal femur from each animal were imaged using a Skyscan 1072 X-ray 
Microtomograph (Skyscan, Aartselaar, Belgium) set at 50 kV/197 μA and using a 0.5 mm Al filter. 
Images were obtained at 5 μm pixel size (58x magnification) with a rotation step of 0.67° between 
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each image. The 3D image stack was reconstructed using NRecon version 1.4.4 (Skyscan), and the 
trabecular and cortical parameters were measured using methods recommended by Skyscan 
(Salmon, 2009). First, a reference level was found at the level of the growth plate by scrolling down 
from the top of the data-set until the spots formed where the growth plate crossed the slice. Four 
spots were seen in femora and two in tibiae. The trabecular region was then defined as 200 slices 
offset by 50 slices from that reference level as recommended by Skyscan (Figure 1), measured using 
CTan version 1.7.0.2 software (Skyscan). The segmentation process separating mineralised and 
non-mineralised structure was performed by drawing a region of interest (ROI) on one slice to 
include trabecular bone and exclude cortical bone. Around 7–8 ROI were drawn at regular intervals 
throughout the stack. The images were then scrolled down to ensure that ROI in the remaining 
slices, produced by interpolation, did not include cortical and exclude trabecular region while 
performing trabecular bone analysis. Images were thresholded to separate bone (pixels with higher 
grey level) and non-bone (pixels with a lower grey level) by adjusting the grey level until most of the 
image noise (speckle) was removed. The threshold levels finally used in all images were 74–255. 
Average volumetric bone mineral density (BMDv) values were calculated from primary micro-CT 
measurements for trabecular and cortical bone using calibration phantoms.
2.3. Statistics
Data are presented as mean (standard deviation). Comparisons between KO and WT mice were 
made using SigmaPlot (version 11.0 Systat Software Inc., Hounslow). All data were checked for nor-
mality and equal variance and when these tests were passed pair-wise comparisons were made 
using Student’s t-test. Otherwise, a Mann–Whitney test was used. Significance was taken to be 
p < 0.05.
3. Results
3.1. Cortical parameters
Deletion of the Cnr2 receptor increased the mechanical and material properties of cortical bone in 
both males and females, and the corresponding change in appearance can be seen in micro-CT 
images (Figure 2). The bending stiffness of the tibia was increased by 27% in males (p = 0.013) and 
34% in females (p = 0.002) (Figure 3(a)) and the failure load by 28% in males (p = 0.014) and 13% in 
Figure 1. A section through a 
tibia showing the reference 
level (growth plate). Trabecular 
parameters were measured 
in region offset from the 
reference level by 50 slices. 
Cortical geometry was taken 
from the last complete slice 
above the fracture site in three-
point bending (identified in 3D 
reconstructions). Femora were 
processed in a similar way.
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females (p = 0.025) (Figure 3(c)). Equivalent figures for the femur showed significant increases of 
22% for the bending stiffness in females (p = 0.032), although the same increase in stiffness for 
males failed to reach significance, and a 26% increase in the strength in males but no difference in 
females (Figure 3(b) and (d)).
Micro-CT showed that KO mice had a greater axial second moment of area and cortical cross-
sectional area than WT controls (Figure 4). In females, the second moment of area in the KOs was 
more than double that in the WTs and this large difference arose from a significant increase in both 
the outer and inner perimeters (Figure 4(a)). In contrast, the axial second moment of area was only 
about 50% larger in the male KO than the WT and there was no difference in the outer perimeter, 
while the inner perimeter increased significantly (Figure 4(c) and (d)). No differences were found in 
the cortical thicknesses measured in the tibiae. A similar pattern was found in the femur, with an 
increase in the second moment of area in both males and females, but in this bone both the inner 
and outer perimeters increased and the cortices were significantly thinner, being reduced by 33% in 
the males (p = 0.024) and by 58% in the females (p = 0.003).
Values for the modulus and density of cortical bone are shown in Figure 5. Deleting Cnr2 had no 
effect on the modulus of the cortical bone matrix in females, the average being 19.68 (0.54) GPa in 
both tibia and femur of KO and WT. In males, however, the modulus was significantly greater following 
deletion of Cnr2 by 8% in the tibia, from 17.44 (0.42) to 18.80 (0.56) GPa (p = 0.005) and by 4.5% in the 
femur, although this failed to reach significance. Archimedean densities of the cortical bone tended 
to be slightly higher in KO than WT although this only reached significance in the femur in females.
3.2. Trabecular parameters
Micro-CT measurements of BV/TV showed that deleting Cnr2 increased the amount of trabecular 
bone (Table 1), by 42% in females, which was highly significant. The increase in male BV/TV was only 
Figure 2. 2D representative 
micro-CT images of trabecular 
bone from a tibia of (a) 
12-week-old WT male mouse, 
(b) WT female, (c) Cnr2−/− male 
and (d) Cnr2−/− female.
Note: The Cnr2−/− females had 
significantly more trabecular 
bone than WTs, whereas there 
was no difference between 
males.
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16% and this was not statistically significant. Values for BV/TV in females, however, were much 
smaller than in the males. The increase in BV/TV in the female mice corresponded to significant 
increases in the number of trabeculae, Tb·N, and their thickness, Tb·Th, and a decrease in their 
spacing, Tb·Sp. No significant differences were found in the thickness or separation in the males 
although the increase in Tb·N, came close (p = 0.07).
Figure 3. Mechanical properties 
of tibiae from Cnr2−/− mice 
measured by three-point 
bending compared with 
WT animals. The bending 
stiffnesses of (a) tibiae and (b) 
femora and the failure loads of 
(c) tibiae and (d) femora were 
generally greater in female KO 
animals although this was not 
always significant.
Notes: Data are represented 
as open circles (males), solid 
circles (females) while the 
mean is shown as a bar.
(a) (b)
(c) (d)
Table 1. Micro-CT measures of trabecular bone from the tibiae of male and female Cnr2−/− and 
WT mice
Parameters Males Females
WT KO p WT KO p
Percentage of BV/TV 17.7 (4.6) 20.5 (2.3) 0.30 7.81 (0.62) 11.08 (0.78) <0.001
Volume of BMD (g cm−3) 0.242 (0.052) 0.312 (0.029) 0.057 0.181 (0.013) 0.182 (0.068) 0.96
Tb. Thickness (mm) 0.063* 0.0617 1.00 0.055 0.058 0.016
0.057, 0.071 0.0612, 0.0618 0.055, 0.056 0.057, 0.058
Tb. Separation (mm) 0.20 (0.02) 0.17 (0.02) 0.20 0.30 (0.01) 0.25 (0.02) 0.003
Tb. Number 2.74 (0.38) 3.34 (0.40) 0.07 1.41 (0.11) 1.91 (0.14) <0.001
Notes: Values are given as mean (standard deviation) except where the normality test failed when the median,  
(25 and 75%) values are shown. Significant values (p < 0.05) are shown in bold typeface.
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4. Discussion
In this study of cortical and trabecular bone from male and female C57BL/6 mice, from both tibia 
and femur, we have shown that deleting the Cnr2 cannabinoid receptor increases the resistance to 
bending in female mice in both tibia and femur although the strength was only increased in the tibia. 
In males, the changes in stiffness were similar but smaller, while the increase in strength was found 
in both bones. Only the female animals showed increases in the amount and organisation of 
trabecular bone. Previous studies have concentrated largely on trabecular bone from one location, 
the proximal tibia, and sometimes only in females, whereas with the mice made available to us here 
we were aiming to obtain a more comprehensive assessment of the effects of Cnr2 inactivation on 
the skeleton.
In the diaphysis, stiffness and strength were increased by enlarging the geometrical properties 
while leaving the material properties unchanged. For a beam in bending, the stiffness is proportional 
to the product of the modulus and the second moment of area; and in this study, we found that it 
was the second moment of area that was increased. Different contributions from inner and outer 
diaphyseal surfaces were found in males and females with much more pronounced effects on both 
inner and outer perimeter in females but greater effects on the inner, enodosteal, surface in males. 
This would reflect increased osteoclast function in both sexes, resorbing the endosteal surface as 
reported by Ofek et al. (2006) and Sophocleous et al. (2011), but only significantly increased osteo-
blastic activity forms new bone on the periosteal surface in females. Addition of material to the 
outside of a tubular structure, such as the diaphysis, has a greater effect than removing internal 
material due to the dependence of the second moment of area on the fourth power of the radius.
Figure 4. Cortical bone 
geometrical properties of tibiae 
measured by micro-CT. (a) 
Second moment of area and 
(b) cross-sectional area were 
significantly greater in both 
female and male Cnr2−/− mice 
tibiae than in the WT controls. 
The outer perimeter (c) was 
larger only in female knockouts, 
whereas the inner perimeter (d) 
was larger in both female and 
male knockouts.
(a) (b)
(c) (d)
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Previous studies were agreed about enhanced osteoporosis in elderly Cnr2−/− mice but disagreed 
about whether peak bone mass was unaffected at 3 months (Idris et al., 2008; Sophocleous et al., 
2011) or reduced (Ofek et al., 2006). Sophocleous, Idris, and Ralston (2014) have also recently 
reported different responses depending on the strain of mouse used, with deletion of Cnr2 in mice 
from a CD1 strain resulting in an increase in BV/TV. In this study, using C57BL/6 mice, we found that 
inactivating Cnr2 also led to an increased amount of trabecular bone (BV/TV) at three months. This 
was only significant in females although males showed a similar trend and larger numbers might 
have made this difference significant. Unfortunately, these were the only mice available to us, but 
they mark a stage at which bone growth is at its fastest. After 12 weeks-of-age, the rate of growth 
in C57BL/6 mice is starting to slow and skeletal maturity is reached at about 4 months (Somerville, 
Aspden, Armour, Armour, & Reid, 2004). Ideally, larger numbers at more time points are required to 
cover growth and maturity but could not be obtained for this study. Differences reported between 
studies could arise from a variety of sources, even within one mouse strain, including competing 
stimuli (Armour, van’t Hof, Grabowski, Reid, & Ralston, 1999), and even husbandry (Khalid, 2013; 
Reliene & Schiestl, 2006). The small numbers of animals are a limitation of this study but the data 
were normally distributed and we found many significant differences. Low power may mean that 
some subtle differences may have been missed but does not affect those that are significant. It is 
not unusual for femur and tibia to yield slightly different results (Ferguson, Ayers, Bateman, & Simske, 
2003; Schriefer et al., 2005), and this is the reason why we wanted to measure both bones, given the 
small numbers of animals, in order not to miss anything of importance.
In conclusion, we have shown that preventing expression of the cannabinoid receptor Cnr2 in 
C57BL/6 mice up to 3 months of age enhanced bone formation in females, resulting in increased 
bending stiffness and bone volume in these animals. Results in males were less pronounced but still 
Figure 5. The densities of (a) 
tibiae and (b) femora showed 
only a small increase in Cnr2−/− 
female femora. The elastic 
modulus of (c) tibiae and (d) 
femora was greater only in 
male Cnr2−/− tibiae.
(a) (b)
(c) (d)
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anabolic. This offers some support for suggestions that targeting CNR2 in humans might be 
therapeutically interesting as a treatment for osteopenic disorders (Sophocleous et al., 2011), 
especially if the effects are more pronounced in females as osteoporosis, for instance, is far more 
common in females. CNR2 is found in all three types of bone cell in greater amounts than the CNR1 
receptor (Idris et al., 2005) and, unlike CNR1, it is not found in the brain, so targeting CNR2 should 
minimise psychotropic side-effects. In addition, activating CNR2 is reported to be a growth stimulator 
for haematopoietic cells leading to macrophages, B- and T-lymphocytes (Valk et al., 1997), to have 
pain-relieving effects (Anand et al., 2008), while inverse agonists of CNR2 inhibited IL-6-induced 
immunoglobulin (Feng, Milcarek, & Xie, 2014). Such a range of potentially beneficial effects of CNR2 
is supported in this study.
Acknowledgements
We thank Dr J.S. Gregory for assistance with Image J and 
Mr K. Mackenzie for assistance with Micro-CT analysis.
Funding
ABK was funded by a University of Aberdeen, Institute of 
Medical Sciences studentship and the Overseas Research 
Students Awards Scheme.
Author details
Aysha B. Khalid1,2
E-mail: khalidaysha2000@gmail.com
Simon R. Goodyear1
E-mail: Simon.goodyear@score-group.com
Ruth A. Ross3,4
E-mail: ruth.ross@utoronto.ca
Richard M. Aspden1
E-mail: r.aspden@abdn.ac.uk
1  Musculoskeletal Research Programme, Institute of Medical 
Sciences, University of Aberdeen, Foresterhill, Aberdeen 
AB25 2ZD, Scotland, UK.
2  Department of Orthopaedic Surgery, University of Tennessee 
Health Science Center, Memphis, TN 38163, USA.
3  Kosterlitz Centre for Therapeutics, Institute of Medical 
Sciences, University of Aberdeen, Foresterhill, Aberdeen, 
AB25 2ZD, Scotland, UK.
4  Department of Pharmacology and Toxicology, University of 
Toronto, Toronto, Canada.
Citation information
Cite this article as: Effects of deleting cannabinoid 
receptor-2 on mechanical and material properties of 
cortical and trabecular bone, A.B. Khalid, S.R. Goodyear, 
R.A. Ross & R.M. Aspden, Cogent Engineering (2015), 2: 
1001015.
References
Anand, U., Otto, W. R., Sanchez-Herrera, D., Facer, P., Yiangou, Y., 
Korchev, Y., … Anand, P. (2008). Cannabinoid receptor CB2 
localisation and agonist-mediated inhibition of capsaicin 
responses in human sensory neurons. Pain, 138, 667–680. 
doi:10.1016/j.pain.2008.06.007
Armour, K. E., van’t Hof, R. J., Grabowski, P. S., Reid, D. M., & 
Ralston, S. H. (1999). Evidence for a pathogenic role 
of nitric oxide in inflammation-induced osteoporosis. 
Journal of Bone and Mineral Research, 14, 2137–2142. 
doi:10.1359/jbmr.1999.14.12.2137
Bab, I. A. (2007). Regulation of skeletal remodeling by the 
endocannabinoid system. Annals of the New York 
Academy of Sciences, 1116, 414–422.  
doi:10.1196/annals.1402.014
Buckley, N. E., McCoy, K. L., Mezey, É., Bonner, T., Zimmer, A., 
Felder, C.C., … Zimmer, A. (2000). Immunomodulation 
by cannabinoids is absent in mice deficient for the 
cannabinoid CB2 receptor. European Journal of 
Pharmacology, 396, 141–149.  
doi:10.1016/S0014-2999(00)00211-9
Feng, R., Milcarek, C., & Xie, X.-Q. (2014). Antagonism of 
cannabinoid receptor 2 pathway suppresses IL-6-induced 
immunoglobulin IgM secretion. BMC Pharmacology and 
Toxicology, 15, 30. doi:10.1186/2050-6511-15-30
Ferguson, V. L., Ayers, R. A., Bateman, T. A., & Simske, S. J. 
(2003). Bone development and age-related bone loss in 
male C57BL/6J mice. Bone, 33, 387–398.  
doi:10.1016/S8756-3282(03)00199-6
Goodyear, S. R., & Aspden, R. M. (2012). Mechanical properties 
of bone ex vivo. Methods in Molecular Biology, 816,  
555–571. doi:10.1007/978-1-61779-415-5_35
Huesa, C., Yadav, M. C., Finnilä, M. A., Goodyear, S. R., Robins, S. P., 
Tanner, K. E., ... Farquharson, C. (2011). PHOSPHO1 is 
essential for mechanically competent mineralization 
and the avoidance of spontaneous fractures. Bone, 48, 
1066–1074. doi:10.1016/j.bone.2011.01.010
Idris, A. I., & Ralston, S. H. (2010). Cannabinoids and bone: 
Friend or foe? Calcified Tissue International, 87, 285–297. 
doi:10.1007/s00223-010-9378-8
Idris, A. I., Sophocleous, A., Landao-Bassonga, E., Canals, M., 
Milligan, G., Baker, D., … Ralston, S. H. (2009). Cannabinoid 
receptor type 1 protects against age-related osteoporosis 
by regulating osteoblast and adipocyte differentiation 
in marrow stromal cells. Cell Metabolism, 10, 139–147. 
doi:10.1016/j.cmet.2009.07.006
Idris, A. I., Sophocleous, A., Landao-Bassonga, E., van’t Hof, R. J., 
& Ralston, S. H. (2008). Regulation of bone mass, osteoclast 
function, and ovariectomy-induced bone loss by the type 2 
cannabinoid receptor. Endocrinology, 149, 5619–5626. 
http://dx.doi.org/10.1210/en.2008-0150
Idris, A. I., van’t Hof, R. J., Greig, I. R., Ridge, S. A., Baker, D.,  
Ross, R. A., & Ralston, S. H. (2005). Regulation of bone mass, 
bone loss and osteoclast activity by cannabinoid receptors. 
Nature Medicine, 11, 774–779. doi:10.1038/nm1255
Khalid, A. B. (2013). Regulation of bone by cannabinoid and 
cannabinoid-like receptors (PhD thesis). University of 
Aberdeen, Aberdeen, SD.
Mkukuma, L. D., Skakle, J. M. S., Gibson, I. R., Imrie, C. T., 
Aspden, R. M., & Hukins, D. W. L. (2003). Effect of the 
proportion of organic material in bone on thermal 
decomposition of bone mineral: An investigation 
of a variety of bones from different species using 
thermogravimetric analysis coupled to mass 
spectrometry, high temperature X-ray diffraction and 
Fourier transform infra-red spectroscopy. Calcified 
Tissue International, 75, 321–328. doi:10.1007/
s00223-004-0199-5
Ofek, O., Karsak, M., Leclerc, N., Fogel, M., Frenkel, B., Wright, K., 
… Bab, I. (2006). Peripheral cannabinoid receptor, 
CB2, regulates bone mass. Proceedings of the National 
Academy of Sciences, 103, 696–701. doi:10.1073/
pnas.050418710
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 A
be
rd
ee
n]
 at
 08
:23
 21
 A
pr
il 2
01
5 
Page 9 of 9
Khalid et al., Cogent Engineering (2015), 2: 1001015
http://dx.doi.org/10.1080/23311916.2014.1001015
© 2015 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license.
You are free to: 
Share — copy and redistribute the material in any medium or format  
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made.  
You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.  
No additional restrictions  
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Cogent Engineering (ISSN: 2331-1916) is published by Cogent OA, part of Taylor & Francis Group. 
Publishing with Cogent OA ensures:
• Immediate, universal access to your article on publication
• High visibility and discoverability via the Cogent OA website as well as Taylor & Francis Online
• Download and citation statistics for your article
• Rapid online publication
• Input from, and dialog with, expert editors and editorial boards
• Retention of full copyright of your article
• Guaranteed legacy preservation of your article
• Discounts and waivers for authors in developing regions
Submit your manuscript to a Cogent OA journal at www.CogentOA.com
Reliene, R., & Schiestl, R. H. (2006). Differences in animal 
housing facilities and diet may affect study outcomes—A 
plea for inclusion of such information in publications. 
DNA Repair, 5, 651–653. doi:10.1016/j.dnarep.2006.02.001
Salmon, P. L. (2009). Morphometric parameters measured 
by Skyscan CT-analyser software. Kontich: Bruker 
MicroCT.
Schriefer, J. L., Robling, A. G., Warden, S. J., Fournier, A. J., 
Mason, J. J., & Turner, C. H. (2005). A comparison of 
mechanical properties derived from multiple skeletal 
sites in mice. Journal of Biomechanics, 38, 467–475. 
doi:10.1016/j.jbiomech.2004.04.020
Somerville, J. N., Aspden, R. M., Armour, K. E., Armour, K. J., 
& Reid, D. M. (2004). Growth of C57Bl/6 mice and the 
material and mechanical properties of cortical bone 
from the tibia. Calcified Tissue International, 74, 469–475. 
doi:10.1007/s00223-003-0101-x
Sophocleous, A., Idris, A. I., & Ralston, S. H. (2014). Genetic 
background modifies the effects of type 2 cannabinoid 
receptor deficiency on bone mass and bone turnover. 
Calcified Tissue International, 94, 259–268. doi:10.1007/
s00223-013-9793-8
Sophocleous, A., Landao-Bassonga, E., van’t Hof, R. J., Idris, A. I., 
& Ralston, S. H. (2011). The type 2 cannabinoid receptor 
regulates bone mass and ovariectomy-induced bone 
loss by affecting osteoblast differentiation and bone 
formation. Endocrinology, 152, 2141–2149. doi:10.1210/
en.2010-093
Valk, P., Verbakel, S., Vankan, Y., Hol, S., Mancham, S., 
Ploemacher, R., … Delwel, R. (1997). Anandamide, a 
natural ligand for the peripheral cannabinoid receptor is 
a novel synergistic growth factor for hematopoietic cells. 
Blood, 90, 1448–1457.
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 A
be
rd
ee
n]
 at
 08
:23
 21
 A
pr
il 2
01
5 
